Bora CDMO Bora CDMO

X

Digital content for Onyx Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Onyx Pharmaceuticals
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
249 E. Grand Avenue South, San Francisco, CA 94080
Telephone
Telephone
+1 650.266.0000
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.bloomberg.com/news/articles/2020-05-05/amgen-wins-ruling-on-patents-for-kyprolis-cancer-drug

Christopher Yasiejko BLOOMBERG
05 May 2020

https://www.fiercebiotech.com/biotech/after-exiting-troubled-merrimack-former-ceo-becomes-new-chief-at-yumanity

Ben Adams FIERCE BIOTECH
10 Jul 2019

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-onyx-settle-cancer-drug-patent-litigation/articleshow/69591844.cms

ECONOMIC TIMES
01 Jun 2019

https://www.moneycontrol.com/news/business/natco-settles-patent-dispute-with-onyx-therapeutics-for-blood-cancer-drug-carfilzomib-4043701.html

MONEYCONTROL
31 May 2019

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-onyx-settle-cancer-drug-patent-litigation/articleshow/69591844.cms

ECONOMIC TIMES
30 May 2019

https://insight.rpxcorp.com/litigation_documents/13149171

PATENT LITIGATION
24 Nov 2018

https://insight.rpxcorp.com/litigation_documents/13149172

PATENT LITIGATION
24 Nov 2018

https://insight.rpxcorp.com/litigation_documents/13093523

PATENT LITIGATION
19 Oct 2018

https://www.pharmacompass.com/pdf/news/kyprolis-carfilzomib-onyx-therapeutics-v-cipla-limited-1525071239.pdf

PATENT LITIGATION
20 Apr 2018

https://www.pelotontherapeutics.com/2018mar22-press-release

PRESS RELEASE
22 Mar 2018
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY